Drug Research
Prior To FDA Prurigo Nodularis Ruling, Dupixent Wins Again
Dupixent, the immunology favourite developed by Sanofi and Regeneron Pharmaceuticals, is still on the rise. It has received back-to-back approvals this year for the...
IT & Data Management
FDA Experts Favor ALS Drug Amylyx, Shifting Former Stance
A group of Food and Drug Administration advisers has recently come out in favour of a carefully monitored ALS drug, increasing the likelihood that...
Press Releases
Airnov to exhibit range of healthcare packaging solutions at upcoming Connect in Pharma event in Geneva
Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, will be exhibiting a range of solutions available to customers worldwide at the upcoming...
Press Releases
“Genome Editing of Immune Cells” – New Lonza Virtual Event
On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery....
Drug Research
Long-Awaited Daxxify By Revance Will Compete With Botox
Revance Therapeutics may soon run into an identity problem with a product that is so eagerly awaited that some people mistakenly call it by...
Clinical Trials
Trodelvy Breast Cancer Drug Makes A Spectacular Comeback
After unimpressive evidence on tumour progression, many Gilead Sciences investors have stopped believing in Trodelvy in HR-positive, HER2-negative breast cancer. But now that the...
News
3 Unusual Foods and Drinks You Should Try at Least Once
If you are a total foodie and you’re looking for some inspiration, you’ve come to the right place. Food trends made for the Gram...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read